ROG.SW - Roche Holding AG
NEXT EARNINGS:
Jul 23, 2026
EPS Est: $10.76
|
Rev Est: $31.5B
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
Market Cap:
297.70B
Volume:
1,206,467
Avg Volume:
1,090,399
52 Week Range:
231.9-374.9
Sector:
Healthcare
Industry:
Drug Manufacturers - General
Beta:
0.20
Last Dividend:
$9.70
Exchange:
SIX
Country:
CH
Employees:
103,249
IPO Date:
1995-08-03
EPS (TTM):
16.18
P/E Ratio:
20.28
Revenue (TTM):
61.52B
Total Assets:
100.70B
Total Debt:
34.44B
Cash & Equiv:
5.58B
Rev Growth (5Y):
1.1%
EPS Growth (5Y):
-0.7%
FCF Growth (5Y):
4.2%
ROCE:
26.5%
Debt/Equity:
1.02
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-01-29 | $6.81 | $8.58 | -20.6% | $30.6B | $31.1B | -1.7% |
| 2025-07-24 | $4.61 | $10.46 | -55.9% | $15.9B | $15.0B | +6.0% |
| 2025-01-30 | $2.52 | $8.40 | -70.0% | $30.6B | $30.8B | -0.4% |
| 2024-10-23 | $7.78 | $9.37 | -17.0% | $30.8B | $29.6B | +3.9% |
| 2024-04-26 | $5.42 | $8.48 | -36.1% | $28.9B | $29.3B | -1.1% |
| 2023-11-29 | $8.88 | $10.40 | -14.6% | $29.8B | $30.3B | -1.7% |
| 2023-04-26 | $4.87 | $8.78 | -44.5% | $31.0B | $31.0B | +0.1% |
| 2022-06-30 | $10.53 | $11.02 | -4.4% | $32.3B | $32.1B | +0.5% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 61.52B | 62.40B | 60.44B | 63.28B | 62.80B | 58.32B | 63.75B | 59.50B | 55.75B | 52.64B | 50.40B | 49.87B |
| Net Income | 12.88B | 8.28B | 11.50B | 12.42B | 13.93B | 14.29B | 13.50B | 10.50B | 8.63B | 9.58B | 8.86B | 9.33B |
| EPS | 16.18 | 10.36 | 14.39 | 15.53 | 16.39 | 16.72 | 15.77 | 12.30 | 10.12 | 11.24 | 10.41 | 10.99 |
| Total Assets | 100.70B | 101.80B | 90.47B | 88.15B | 92.32B | 86.14B | 83.09B | 78.52B | 76.68B | 76.82B | 75.76B | 75.54B |
| Total Debt | 34.44B | 36.35B | 30.78B | 26.54B | 32.55B | 15.41B | 15.58B | 18.77B | 18.96B | 22.36B | 23.25B | 25.71B |
| Cash & Equivalents | 5.58B | 6.97B | 5.38B | 4.99B | 6.85B | 5.73B | 6.08B | 6.68B | 4.72B | 4.16B | 3.73B | 3.74B |
| Operating Cash Flow | 17.83B | 20.09B | 16.09B | 17.89B | 20.57B | 18.16B | 22.39B | 19.98B | 18.02B | 15.00B | 15.25B | 15.93B |
| Free Cash Flow | 14.08B | 15.09B | 11.45B | 13.34B | 16.02B | 11.47B | 18.88B | 15.94B | 14.52B | 10.86B | 11.78B | 12.96B |
| FCF per Share | 17.69 | 18.93 | 14.33 | 16.67 | 18.85 | 13.42 | 22.06 | 18.66 | 17.02 | 12.74 | 13.85 | 15.27 |
| Book Value | 33.80B | 31.77B | 29.32B | 27.99B | 24.49B | 36.34B | 32.75B | 27.62B | 26.44B | 23.91B | 20.98B | 19.59B |
| Cash & ST Investments | 15.48B | 17.32B | 10.51B | 9.77B | 13.03B | 12.33B | 11.87B | 13.12B | 12.00B | 9.13B | 9.21B | 11.72B |
| ROC Equity | 0.38 | 0.26 | 0.39 | 0.44 | 0.57 | 0.39 | 0.41 | 0.38 | 0.33 | 0.40 | 0.42 | 0.48 |